Safety and Efficacy of Adenovirus Carrying Hepatocyte Growth Factor Gene by Percutaneous Endocardial Injection for Treating Post-infarct Heart Failure: A Phase IIa Clinical Trial. [electronic resource]
Producer: 20190606Description: 125-130 p. digitalISSN:- 1875-5631
- Adenoviridae -- genetics
- Adult
- Aged
- Cardiac Catheterization
- Echocardiography
- Follow-Up Studies
- Gene Transfer Techniques
- Genetic Therapy -- adverse effects
- Heart Failure -- etiology
- Heart Ventricles -- diagnostic imaging
- Hepatocyte Growth Factor -- genetics
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- complications
- Tomography, Emission-Computed, Single-Photon
- Transgenes
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.